methoxyhydroxyphenylglycol has been researched along with sertraline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hori, H; Ikenouchi-Sugita, A; Nakamura, J; Otani, K; Suzuki, A; Ueda, N; Umene-Nakano, W; Yoshimura, R | 1 |
1 trial(s) available for methoxyhydroxyphenylglycol and sertraline
Article | Year |
---|---|
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Severity of Illness Index; Treatment Outcome; Young Adult | 2010 |